Molecular Diagnosis of Chikungunya virus (CHIKV) and Dengue virus (DENV) and its concomitant circulation in South Indian population  by Dayakar, Seetha et al.
Short Communication
Virology Reports 5 (2015) 56–62
Contents lists available at ScienceDirect
Virology Reports
j ourna l homepage: www.e lsev ie r .com/ locate /v i repMolecular Diagnosis of Chikungunya virus (CHIKV)
and Dengue virus (DENV) and its concomitant
circulation in South Indian populationRemadevi a,
hakrishna Pillai aSeetha Dayakar a,b, Iravathy K. Goud b, Heera Pillai a, Viji
Sanjai Dharmaseelan a, Radhakrishnan R. Nair a,⁎, M. Rad
a Department of Laboratory Medicine and Molecular Diagnostics, Rajiv Gandhi Centre for Biotechnology, Poojappura, Thycaud,
Thiruvananthapuram 695014, Kerala, India
b Department of Molecular Biology and Cytogenetics, Apollo Health City, Jubilee Hills, Hyderabad500033,Andhra Pradesh, India
a r t i c l e i n f o a b s t r a c ts has been
d. SeveralArticle history:
Received 27 October 2014015
⁎ Corresponding author. Tel.: +91 471
E-mail address: radhakrishnan@rgcb.
http://dx.doi.org/10.1016/j.virep.2015.05
2214-6695/© 2015 The Authors. Publi
(http://creativecommons.org/licensesConcomitant circulation of dengue and chikungunya viruse
sporadically reported and needs to be individually diagnosediagnosis
o viral in-
l presenta-
and CHIKV
agnosis to
tions. The
24 DENV/Received in revised form 13 April 2
Accepted 5 May 2015
Available online 12 May 2015
Keywords:
CHIKV
DENVraPradesh
R (reverse
3.8% DENV
s obtained
nof 16.1%,
.1% of the
and Kerala
en access
D license
-nd/4.0/).sensitive molecular diagnostics are currently deployed for the
of both DENV and CHIKV, it is very difﬁcult to delineate the tw
fections based on symptomology, as both share similar clinica
tion. Due to the overlapping nature of clinical signs in DENV
infections, there is an urgent need for early and accurate di
avoid outbreaks aimed at initiating disease speciﬁc interven
study encompasses the diagnosis of clinically suspected 10
CHIKV patient samples which were collected from Andh
(AP) and Kerala, India by using in-house developed RT-PC
transcription-polymerase chain reaction). The results show 4
RNA infection and32% CHIKV RNA infection of the total sample
fromAP. In contrast, samples fromKerala showdengue infectio
CHIKV infection of 2.3%. In our study, we found that 23%, 0
samples were concomitant circulation for CHIKV/DENV in AP
respectively, suggesting the co-infection of these two viruses.
© 2015 The Authors. Published by Elsevier B.V. This is an op
article under the CC BY-NC-N
(http://creativecommons.org/licenses/by-ncReverse transcription PCR
Concomitant circulation2529564; fax: +91 4712346333.
res.in (R.R. Nair).
.001
shed by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
/by-nc-nd/4.0/).
1. Introduction
by a class
aused by
s by day-
s such as
h the dis-
viruses in
about the
ts similar
tes med-
e need of
ening of
57S. Dayakar et al. / Virology Reports 5 (2015) 56–62Having known for itsmenace in tropical countries such as Africa and Asia, dengue fever is caused
of pathogens called as Flavivirus that belongs to the family of Flaviviridae and Chikungunya, being c
the Alphavirus of family Togaviridae (Buchen et al., 2010). Both diseases are transmitted to human
biting Aedes aegypti and Aedes albopictus mosquitoes and almost cause similar clinical symptom
fever, rashes, joint pain; headache, fatigue, nausea, vomiting, and body pain are the hallmark for bot
eases that makes diagnosis difﬁcult (Konstantin et al., 2007). Concomitant circulation of both these
humans was reported and apprehended by serological analysis but their results did not pave clue
on-going infectionwith both the viruses (Arankalle et al., 2007). Co-infection of these viruses presen
clinical signs, but different disease patterns. Unavailability of viral speciﬁc diagnostic tools complica
ical management strategies and hence clinically viable and easily available molecularmarkers are th
the hour. Here, a study was conducted to establish a handy diagnosis method for the scre
chikungunya and dengue fever through in-house designed RT-PCR approach.
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V sample
NV alone1024 patient blood samples from Kerala and Andhra Pradesh were tested for the screening of de
chikungunya. In the current cross-sectional study, we found that nearly 46/105 samples (43.8%)wer
for DENV, 34/105 samples (32%) were positive for CHIKV and 24/105 samples (23%) were positi
presence of both viruses in the Andhra Pradesh region. In contrast to the above ﬁgures, patients fro
were found to be positive for dengue with 16.1% (148/919), positive for CHIKV at 2.3% (21/919) an
ingly only 0.1% (1/919) of people were found to be carrying both the viruses. Serology analysis usin
IgM in Andhra Pradesh and Kerala showed 60.9% (64/105) and18.8% (173/919), respectively (Table
ther validate our above ﬁndings, we ran RT-PCR to detect the presence of DENV RNA in blood sampl
Andhra Pradesh and Kerala patients. We concluded that, in Andhra Pradesh alone, 45.6% (21/46) of
ples showed positive for dengue serotype-2; 54.6% (25/46) showed positive for more than one den
such as dengue type 2 and 3; co-infection was detected in 39.1%; 0.6% (4/46) of the samples bein
for type 2 and 4; mere 6.5%of all patient samples showed the presence of D-1, D-1/2, D-1/4, D-1
D-1/3/4, D-2/3/4 serotypes (Table 4).
148/919 samples from Kerala were tested for DENV RNA by RT-PCR. Five samples could not be g
due to low copy number and 143 samples were analyzed for dengue serotype speciﬁc PCR. Am
samples, dengue serotype 2 occupied 35.6% (51/143) and the remaining 64.3% (92/143) of the
were diagnosed with other subtypes of dengue such as D-4 of 16.7% (24/143), D-3 of13.2%
respectively. Co-infection of D-2 and D-4 was found to be 12.5% (18/143), D-2 and D-3 were 7.6%
and co-infection was 13.9% (20/143) of the samples tested (Table 4).
The BLAST data conﬁrmed the ampliﬁed products to be that of DENV and CHIKV sequen
phylogenetic analyses of the DENV sequences revealed that the ampliﬁed DENV samples cluste
with DENV-2, DENV-3 and DENV-4 genotypes (Fig. 2), while the representative sequenced CHIK
clustered with central African genotype (Fig. 3), results of RT-PCR showed statistical signiﬁcant DE
Table 1
Case deﬁnitions.
Case Symptoms
Suspected An acute illness characterized by sudden onset of fever with several of the following symptoms:
joint pain, headache, backache, photophobia, arthralgia, rashes, etc.
Probable Above symptoms with positive serology either when single serum sample was taken during
acute onset phase or during the convalescence
Conﬁrmed A conﬁrmation was done based on the following criteria:
1. 4-fold difference in HI antibody levels
2. Detection of IgM antibodies against Chikungunya virus
3. Virus isolation from plasma on cell cultures
4. Detection of CHIKV genomic RNA by RT-PCR
vs. co-infectionsCHIKVandDENV at 59.9% vs. 23.1% (pvalue=0) andCHIKV alone vs. co-infection CHIKVand
DENV at 34.3% vs. 23.1% (p value b 0.001).
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Table 2
Oligonucleotide primers used and the expected size of the products.
Primer Sequence (5′–3′) Genome position Expected size (bp)
DEN-F 5′-TCAATATGCTGAAACGCGCGAGAAACCG-3′ 134–161a –
DEN-CR 5′-TTGCACCAACAGTCAATGTCTTCAGGTTC-3′ 616–644a 511
DEN1-R 5′-CGTCTCAGTGATCCGGGGG-3′ 568–586b 482
DEN2-R 5′-CGCCACAAGGGCCATGAACAG-3′ 232–252b 119
DEN3-R 5′-TAACATCATCATGAGACAGAGC-3′ 400–421b 290
DEN4-R 5′-CTCTGTTGTCTTAAACAAGAGA-3′ 506–527b 392
a The genome positions of Dl and D2 are given according to the Dengue virus type 2 published sequence (Lanviotti et al., 1992).
b Themappositions of theDengue virus type-speciﬁc primers (TS1, TS2, TS3, and TS4) are given according to their respective published
sequences (Lanviotti et al., 1992).
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There have been very few reports on the co-existence of CHIKV and DENV, particularly in thos
areas endemic to CHIKV and DENV. Infectionswith CHIKV and DENV present similar clinical sympto
tients. Accordingly, there have been reports of co-infectionwith CHIKV and DENV in human populat
in Asian countries. Some of the data on co-infection is based on the serological diagnosis of the pat
ples but it suggests little details on live infection. In this context, we have proven that the in-house
primers for RT-PCR-based tool enabled a diverse yet commendable diagnosis of CHIKV and DENV
co-infections of both the viruses. In our study, we found that 23% (24/105) and 0.1% (1/919) of th
were positive for both CHIKV as well as DENV in AP and Kerala respectively, suggesting the co-ex
these two viruses in these patients. Although the virulence and viral loads of CHIKV strains isolat
our study is yet to be established, the clinical spectrum of the two infections is very much simila
co-exist in the same host (Vanlandingham et al., 2005). Our study also reﬂects a comparative study
features betweenmonotypic and dual infection caseswith Chikungunya virus andDengue virus inwe
India (Debjani et al., 2012).
The sequence obtained from the RT-PCR assay can be used for phylogenetic neighborhood jo
analysis and genotyping of the isolates. Thus, the assay can also serve as a tool for rapid clustering
for the genotyping of viruses fromdifferent outbreaks. RT-PCR can be applied as a potential rapid tes
dengue and chikungunya viral infections simultaneously in clinical samples along with the determ
DENV serotypes.
3.1. Concluding remarks
False negatives are always plausible if diagnostic tests for both the viruses are not performed
shown that it is possible for clinicians to use simple clinical and laboratory variables to predict these
Table 3
Results of reverse transcriptase polymerase chain reaction and ELISA tested for dengue and chikungunya⁎.
Place Positive for
dengue
RT-PCR
Dengue IgM
by ELISA
Positive for
chikungunya
RT-PCR
Co-infection
CHIKV/DENV
DENV vs.
Co-infection
CHIKV and DENV
p value (n = 1024)
CHIKV vs. Co-infection
CHIKV and DENV
p value (n = 1024)
Andhra
Pradesh
43.8% (46/105) 60.9% (64/105) 32% (34/105) 23% (24/105) 0 (59.9% vs. 23.1%) b0.001 (34.3% vs. 23.1%)
Kerala 16.1% (148/919) 18.8% (173/919) 2.3% (21/919) 0.1% (1/919)
⁎ Desired signiﬁcance level 0.01.
for more personalized treatment. Though, we have described an easy technique here, we are unaware of the
sensitivity of the test as the former requires periodic follow-up of the patients who had received respective
differen-
settings.
Table 4
Detection of dengue serotype speciﬁc by reverse transcriptase polymerase chain reaction in patient samplesa.
Place Dengue Serotype speciﬁc RT-PCR
D-2 Other than D-2 b D-2 vs. CHIKV
p value (n = 189) ⁎
Other than D2 vs. CHIKV
p value (n = 189) ⁎
Kerala 35.6% (51/143) 64.3% (92/143) b0.001 0
Andhra Pradesh 45.6% (21/46) 54.3% (25/46) (38% vs. 17.4) (62% vs. 174%)
a Five samples that could not be genotyped, due to low copy number of DENV RNA.
b D-1, D-1/2, D-1/4, D-1/3, D-3/4, D-1/3/4, D-2/3/4.
⁎ Desired signiﬁcance level 0.01.
59S. Dayakar et al. / Virology Reports 5 (2015) 56–62treatments on diagnosis; having said that, we believe this methodwould improve the diagnosis and
tiation of viral co-infection, particularly in tropical areas where health cares are in resource-limited
4. Materials and methodscted with
patients
between
V/DENV),
e molec-
ple vials
or furtherTo investigate concomitant circulation of the two viruses, 3–4 ml of blood samples were colle
sterile Vaccutainer™ containing K3 anti-coagulant from clinically suspected DENV/CHIKV 1024
who were enrolled after their consent obtained, Apollo Hospitals, Hyderabad, Andhra Pradesh (AP)
August, 2011 and December, 2013 and Thiruvananthapuram (during the local outbreak of CHIK
Kerala, India, respectively (Yergolkar et al., 2006). The case deﬁnition is given in detail in Table 1. Th
ular detection of CHIKV and/or DENVwas done through RT-PCRwith in-house designed primer. Sam
were centrifuged at 1500 rpm for 10 min and plasma/serum was immediately stored at−20 °C f
analysis. The samples were collected as a part of the outbreak investigation.
(A)325 bp
(B)
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Fig. 1. (A) agarose gel analysis of DNAproducts fromRT-PCRof CHIKV samples 1.100 bpDNA ladder, 2.CHIKV positive control, 3–5 patient
sample, 6. Negative control. (B) Agarose gel analysis of DNA products from RT-PCR of RNA samples isolated from dengue viruses. (I) After
ampliﬁcation with consensus primers. (II) After second round ampliﬁcation with type speciﬁc primers TS1, TS2, TS3 and TS4. 1.100 bp
DNA ladder, D1—dengue type 1, D2—dengue type 2,D3—dengue type 3, D4—dengue type 4.
4.1. RT-PCR
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Fig. 2. Bootstrapped NJ tree representing the phylogenetic relationships of the Chikungunya virus isolates with the sequenced
CHIKV–LMMD–RGCB-India isolate at nucleotide level.
60 S. Dayakar et al. / Virology Reports 5 (2015) 56–62RNA was isolated from plasma samples using QIAamp Viral RNA™mini kit (QIAGEN®) accord
manufacturer's instructions. Extracted dengue viral RNA was converted to cDNA using RNA amp
with a highly conserved primer pair, i.e.D1 and D2. Dengue virus sequences that were ampliﬁed a
using second-round ampliﬁcationwith primerD1 and four serotype-speciﬁc primers are given in Table
ed by according to the protocol published elsewhere (Lanviotti et al., 1992). Similarly, according to the
protocol speciﬁc primers were used for the detection of CHIKV (CHIKF — 5′-ACCGGCGTCTACCCATT
nt10237-10258 and CHIKR — 5′-GGGCGGGTAGTCCATGTTGTAGA-3′, nt10544-10566) targeting a
region in the cDNA encoding E1 protein of CHIKV strain 653496 (Accession # AY424803) amplify the
by using thermal cycler (Master cycler, Eppendorf, Germany) (Myers and Carey, 1967; Khan et al., 2
PCR products from the above reactionswere analyzed on2% agarose gel (Fig. 1 A andB). The sequence
were blasted against the NCBI database to ascertain the ampliﬁcation of speciﬁc viral sequences.
Fig. 3. Bootstrapped NJ tree representing the phylogenetic relationships of the Dengue virus−2,3 and 4 isolates with the sequenced DENV–LMMDD–RGCB-India isolate at Nucleotide level. 61
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62 S. Dayakar et al. / Virology Reports 5 (2015) 56–62ELISA for dengue associated IgM was performed as per the manufacturer's instructions
Immunodiagnostica GmbH, Germany).
4.3. PCR sequencing and phylogenetic analysis of CHIKV/DENV virus
The puriﬁed PCR products of representative samples (20 DENV and 9 CHIKV) were sequenc
forward and reverse directions using ABI PRISM 7900 sequencer (Applied Biosystems, CA, USA). Th
ticity of obtained sequences was done by using the BLAST program available at the NCBI. For
comparison, respective standard representative viral sequences were retrieved from GenBank an
with the present study sequences for the construction of phylogenetic relation using Molecular Evo
Genetics Analysis (MEGA 6.0) (Tamura et al., 2013).Statistical analysis was performed with onlin
2-sample z-test to compare sample proportion.
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